CDSCO Panel Asks Glenmark To Justify BE Waiver for FDC Inhalation Suspension With Scientific Evidence Dr. Divya Colin5 July 2025 3:36 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has advised Glenmark...
Indian Pharma market sees 6.9% growth in May: Report Ruchika Sharma19 Jun 2025 3:00 PM ISTNew Delhi: The India pharmaceutical market (IPM) registered a 6.9 percent (on-year) growth in May, primarily propelled by strong performances in...
Batch of Telma AM earlier classified as NSQ now flagged as Spurious Farhat Nasim25 April 2025 8:30 PM ISTNew Delhi: Through a recent revised Drug Alert for January 2025, the Central Drugs Standard Control Organisation (CDSCO) has classified a batch of...
Sun Pharma, Zydus and Glenmark recall various products in US over manufacturing issues Ruchika Sharma14 April 2025 1:30 PM ISTSun Pharma, Zydus, and Glenmark are recalling various products in the US market due to manufacturing-related concerns, the US health regulator...
Glenmark gets CDSCO Panel nod to study Glycopyrronium, Fluticasone Furoate, Vilanterol Powder for Inhalation Dr. Divya Colin10 April 2025 5:45 PM ISTNew Delhi: In line with the revised Phase IV clinical trial protocol of Glycopyrronium 50 mcg plus Fluticasone Furoate 100 mcg plus Vilanterol 25 mcg...
Biocon, Glenmark recall anxiety, high cholesterol medications in US Ruchika Sharma10 April 2025 3:17 PM ISTBiocon and Glenmark are recalling anxiety and high cholesterol medications from US market due to manufacturing concerns, according to the U.S. Food...
State Drug Alert: 93 Drug samples fail To Qualify CDSCO Test Susmita Roy1 March 2025 6:00 PM ISTNew Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central Drug Standard Control...
Glenmark, FDC Recall Hypertension, Glaucoma Drugs in US Farhat Nasim17 Feb 2025 8:17 PM ISTNew Delhi: Drug firms Glenmark Pharmaceuticals and FDC Ltd are recalling products in the US market due to manufacturing issues, according to the US...
Glenmark Rolls Out Generic Xalatan in US, Targets USD 113M Market Farhat Nasim14 Feb 2025 1:20 PM ISTWith the launch of Latanoprost Ophthalmic Solution 0.005% (0.05 mg/mL), Glenmark has introduced its fourth ophthalmic product, expanding its portfolio
Glenmark Pharmaceutical Gets CDSCO Panel Nod To Import and Market Anti-cancer Drug Tislelizumab Dr. Divya Colin31 Jan 2025 6:00 PM ISTNew Delhi: Drug major Glenmark Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Cipla elevates Achin Gupta as new Global Chief Operating Officer Ruchika Sharma29 Jan 2025 1:16 PM ISTMumbai: Cipla has announced the appointment of Achin Gupta, Chief Executive Officer - One India Business (SMP) as the Global Chief Operating Officer...
Corporate Chaos: Glenmark Faces Backlash Over Abrupt Job Cuts Farhat Nasim24 Jan 2025 5:31 PM ISTNew Delhi: Enraged after the alleged abrupt layoff citing redundancy, hundreds of employees of Glenmark Pharmaceuticals' Consumer Care Division, which...
